Table 5.
Variable | Control group (n = 35) | ERAS group (n = 39) | P-value |
---|---|---|---|
Mortality (n) | 0 | 0 | — |
PONV VAS (n) | 0.101 | ||
Mild (0–4) | 22 (62.86%) | 33 (84.62%) | |
Moderate (5–6) | 9 (25.71%) | 4 (10.26%) | |
Severe (7–10) | 4 (11.43%) | 2 (5.13%) | |
Dyspnea (n) | 0(0.00%) | 0 (0.00%) | — |
Surgical site infection/subcutaneous effusion (n) | 1 (2.86%) | 0 (0.00%) | 0.288 |
Stroke (n) | 2 (5.71%) | 1 (2.56%) | 0.493 |
Cardiovascular (n) | 0 (0.00%) | 1 (2.56%) | 0.340 |
Gastrointestinal (n) | 1 (2.86%) | 1 (2.56%) | 0.938 |
Urinary tract (n) | 2 (5.71%) | 1 (2.56%) | 0.493 |
DVT (n) | 0 (0.00%) | 2 (5.71%) | 0.130 |
PONV, postoperative nausea and vomiting; VAS, Visual Analog Scale; DVT, deep vein thrombosis.